Identification	O
of	O
human	B-DNA
TR2	I-DNA
orphan	I-DNA
receptor	I-DNA
response	I-DNA
element	I-DNA
in	O
the	O
transcriptional	B-DNA
initiation	I-DNA
site	I-DNA
of	O
the	O
simian	B-DNA
virus	I-DNA
40	I-DNA
major	I-DNA
late	I-DNA
promoter	I-DNA
[	O
published	O
erratum	O
appears	O
in	O
J	O
Biol	O
Chem	O
1995	O
Nov	O
3	O
;	O
270	O
(	O
44	O
)	O
:	O
26721	O
]	O

A	O
DNA	B-DNA
response	I-DNA
element	I-DNA
(	O
TR2RE-SV40	B-DNA
)	O
for	O
the	O
TR2	B-protein
orphan	I-protein
receptor	I-protein
,	O
a	O
member	O
of	O
the	O
steroid-thyroid	B-protein
hormone	I-protein
receptor	I-protein
superfamily	I-protein
,	O
has	O
been	O
identified	O
in	O
the	O
simian	B-DNA
virus	I-DNA
40	I-DNA
(	I-DNA
SV40	I-DNA
)	I-DNA
+55	I-DNA
region	I-DNA
(	O
nucleotide	B-DNA
numbers	I-DNA
368-389	I-DNA
,	O
5'-GTTAAGGTTCGTAGGTCATGGA-3	O
'	O
)	O
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
,	O
using	O
in	O
vitro	O
translated	O
TR2	B-protein
orphan	I-protein
receptor	I-protein
with	O
a	O
molecular	O
mass	O
of	O
67	B-protein
kilodaltons	I-protein
,	O
showed	O
a	O
specific	O
binding	O
with	O
high	O
affinity	O
(	O
dissociation	O
constant	O
=	O
9	O
nM	O
)	O
for	O
this	O
DNA	O
sequence	O
.	O

DNA-swap	O
experiments	O
using	O
chloramphenicol	B-protein
acetyl-transferase	I-protein
assay	O
demonstrated	O
that	O
androgen	O
can	O
suppress	O
the	O
transcriptional	O
activities	O
of	O
SV40	B-DNA
early	I-DNA
promoter	I-DNA
via	O
the	O
interaction	O
between	O
this	O
TR2RE-SV40	B-DNA
and	O
the	O
chimeric	B-protein
receptor	I-protein
AR/TR2/AR	I-protein
with	O
the	O
DNA-binding	B-protein
domain	I-protein
of	O
the	O
TR2	B-protein
orphan	I-protein
receptor	I-protein
flanked	O
by	O
the	O
N-terminal	B-protein
and	I-protein
androgen-binding	I-protein
domains	I-protein
of	O
the	O
androgen	B-protein
receptor	I-protein
.	O

In	O
addition	O
,	O
this	O
TR2RE-SV40	B-DNA
can	O
function	O
as	O
a	O
repressor	O
to	O
suppress	O
the	O
transcriptional	O
activities	O
of	O
both	O
SV40	B-DNA
early	I-DNA
and	I-DNA
late	I-DNA
promoters	I-DNA
.	O

Together	O
,	O
these	O
data	O
suggest	O
the	O
TR2RE-SV40	B-DNA
may	O
represent	O
the	O
first	O
identified	O
natural	O
DNA	B-DNA
response	I-DNA
element	I-DNA
for	O
the	O
TR2	B-protein
orphan	I-protein
receptor	I-protein
that	O
may	O
function	O
as	O
a	O
repressor	O
for	O
the	O
SV40	O
gene	O
expression	O
.	O

THE	NULL
Journat	NULL
or	NULL
BrorocicaL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

10	NULL
,	NULL
Issue	NULL
of	NULL
March	NULL
10	NULL
,	NULL
pp	NULL
.	NULL

5434-5440	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Identification	NULL
of	NULL
Human	NULL
TR2	NULL
Orphan	NULL
Receptor	NULL
Response	NULL
Element	NULL
in	NULL
the	NULL
Transcriptional	NULL
Initiation	NULL
Site	NULL
of	NULL
the	NULL
Simian	NULL
Virus	NULL
40	NULL
Major	NULL
Late	NULL
Promoter*	NULL
Han-Jung	NULL
Lee	NULL
and	NULL
Chawnshang	NULL
Changt	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
19	NULL
,	NULL
1994	NULL
)	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Human	NULL
Oncology	NULL
and	NULL
the	NULL
Endocrinology-Reproductive	NULL
Physiology	NULL
Program	NULL
,	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
Wisconsin	NULL
,	NULL
Madison	NULL
,	NULL
Wisconsin	NULL
53792	NULL
A	NULL
DNA	NULL
response	NULL
element	NULL
(	NULL
TR2RE-SV40	NULL
)	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
steroid-thyroid	NULL
hormone	NULL
receptor	NULL
superfamily	NULL
,	NULL
has	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
+55	NULL
region	NULL
(	NULL
nucleotide	NULL
numbers	NULL
368-389	NULL
,	NULL
5'-GTTAAGGTTCGTAGGTCATGGA-3	NULL
'	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
,	NULL
using	NULL
in	NULL
vitro	NULL
translated	NULL
TR2	NULL
orphan	NULL
receptor	NULL
with	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
67	NULL
kilodaltons	NULL
,	NULL
showed	NULL
a	NULL
specific	NULL
binding	NULL
with	NULL
high	NULL
affinity	NULL
(	NULL
dissociation	NULL
constant	NULL
=	NULL
9	NULL
nM	NULL
)	NULL
for	NULL
this	NULL
DNA	NULL
sequence	NULL
.	NULL

DNA-swap	NULL
experiments	NULL
using	NULL
chloramphenicol	NULL
acetyl-transferase	NULL
assay	NULL
demonstrated	NULL
that	NULL
androgen	NULL
can	NULL
suppress	NULL
the	NULL
transcriptional	NULL
activities	NULL
of	NULL
SV40	NULL
early	NULL
promoter	NULL
via	NULL
the	NULL
interaction	NULL
between	NULL
this	NULL
TR2RE-SV40	NULL
and	NULL
the	NULL
chimeric	NULL
receptor	NULL
AR/TR2/AR	NULL
with	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
flanked	NULL
by	NULL
the	NULL
N-terminal	NULL
and	NULL
androgen-binding	NULL
domains	NULL
of	NULL
the	NULL
androgen	NULL
receptor	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
TR2RE-SV40	NULL
can	NULL
function	NULL
as	NULL
a	NULL
repressor	NULL
to	NULL
suppress	NULL
the	NULL
transcriptional	NULL
activities	NULL
of	NULL
both	NULL
SV40	NULL
early	NULL
and	NULL
late	NULL
promoters	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
the	NULL
TR2RE-SV40	NULL
may	NULL
represent	NULL
the	NULL
first	NULL
identified	NULL
natural	NULL
DNA	NULL
response	NULL
element	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
that	NULL
may	NULL
function	NULL
as	NULL
a	NULL
repressor	NULL
for	NULL
the	NULL
SV40	NULL
gene	NULL
expression	NULL
.	NULL

Several	NULL
members	NULL
of	NULL
the	NULL
steroid-thyroid	NULL
hormone	NULL
receptor	NULL
superfamily	NULL
,	NULL
including	NULL
the	NULL
androgen	NULL
receptor	NULL
(	NULL
AR	NULL
)	NULL
'	NULL
,	NULL
estrogen	NULL
receptor	NULL
,	NULL
glucocorticoid	NULL
receptor	NULL
,	NULL
progesterone	NULL
receptor	NULL
,	NULL
mineralocorticoid	NULL
receptor	NULL
,	NULL
thyroid	NULL
receptor	NULL
(	NULL
T	NULL
&	NULL
R	NULL
)	NULL
,	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
receptor	NULL
(	NULL
VDR	NULL
)	NULL
,	NULL
and	NULL
retinoid	NULL
acid	NULL
receptor	NULL
(	NULL
RAR	NULL
)	NULL
,	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
the	NULL
control	NULL
of	NULL
vertebrate	NULL
differentiation	NULL
and	NULL
development	NULL
(	NULL
1	NULL
)	NULL
.	NULL

These	NULL
nuclear	NULL
receptors	NULL
act	NULL
as	NULL
trans-regulators	NULL
of	NULL
transcription	NULL
.	NULL

Upon	NULL
binding	NULL
with	NULL
their	NULL
cognate	NULL
ligands	NULL
,	NULL
these	NULL
hormone-receptor	NULL
complexes	NULL
interact	NULL
with	NULL
cis-acting	NULL
DNA	NULL
elements	NULL
,	NULL
termed	NULL
hormone	NULL
response	NULL
elements	NULL
(	NULL
HREs	NULL
)	NULL
,	NULL
to	NULL
modulate	NULL
the	NULL
transcription	NULL
of	NULL
target	NULL
genes	NULL
.	NULL

The	NULL
functional	NULL
structure	NULL
and	NULL
organization	NULL
of	NULL
these	NULL
receptors	NULL
com	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
CA	NULL
55639	NULL
and	NULL
American	NULL
Cancer	NULL
Society	NULL
Grant	NULL
BE	NULL
78a	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

#	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Human	NULL
Oncology	NULL
,	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
Wisconsin	NULL
,	NULL
600	NULL
Highland	NULL
Ave.	NULL
,	NULL
K4/632	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
53792	NULL
.	NULL

Tel	NULL
:	NULL
608-263-0899	NULL
;	NULL
Fax	NULL
:	NULL
608-263-8613	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
AR	NULL
,	NULL
androgen	NULL
receptor	NULL
;	NULL
T	NULL
;	NULL
R	NULL
,	NULL
thyroid	NULL
receptor	NULL
;	NULL
VDR	NULL
,	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
receptor	NULL
;	NULL
RAR	NULL
,	NULL
retinoic	NULL
acid	NULL
receptor	NULL
;	NULL
RXR	NULL
,	NULL
retinoid	NULL
X	NULL
receptor	NULL
;	NULL
hERR1	NULL
,	NULL
human	NULL
estrogen-related	NULL
receptor	NULL
1	NULL
;	NULL
HRE	NULL
,	NULL
hormone	NULL
response	NULL
element	NULL
;	NULL
ERE	NULL
,	NULL
estrogen	NULL
response	NULL
element	NULL
;	NULL
TR2RE	NULL
,	NULL
TR2	NULL
response	NULL
element	NULL
;	NULL
SV40	NULL
,	NULL
simian	NULL
virus	NULL
40	NULL
;	NULL
MLP	NULL
,	NULL
major	NULL
late	NULL
promoter	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
CTS	NULL
,	NULL
charcoal-treated	NULL
FBS	NULL
;	NULL
FBS	NULL
,	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

prise	NULL
a	NULL
variable	NULL
N-terminal	NULL
domain	NULL
involved	NULL
in	NULL
the	NULL
modulation	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
a	NULL
well	NULL
conserved	NULL
DNA-binding	NULL
domain	NULL
with	NULL
two	NULL
zinc	NULL
fingers	NULL
,	NULL
and	NULL
a	NULL
partially	NULL
conserved	NULL
C-terminal	NULL
ligand-binding	NULL
domain	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Human	NULL
testicular	NULL
receptor	NULL
2	NULL
(	NULL
TR2	NULL
)	NULL
is	NULL
one	NULL
of	NULL
the	NULL
first	NULL
orphan	NULL
receptors	NULL
identified	NULL
that	NULL
share	NULL
structural	NULL
homology	NULL
with	NULL
members	NULL
of	NULL
the	NULL
steroid-thyroid	NULL
hormone	NULL
receptor	NULL
superfamily	NULL
(	NULL
3-6	NULL
)	NULL
.	NULL

The	NULL
TR2	NULL
orphan	NULL
receptor	NULL
cDNA	NULL
was	NULL
isolated	NULL
from	NULL
human	NULL
prostate	NULL
and	NULL
testis	NULL
cDNA	NULL
libraries	NULL
with	NULL
a	NULL
probe	NULL
homologous	NULL
to	NULL
a	NULL
highly	NULL
conserved	NULL
DNA-binding	NULL
domain	NULL
common	NULL
to	NULL
steroid	NULL
hormone	NULL
receptors	NULL
.	NULL

The	NULL
TR2	NULL
orphan	NULL
receptor	NULL
cDNA	NULL
encodes	NULL
a	NULL
protein	NULL
of	NULL
603	NULL
amino	NULL
acids	NULL
with	NULL
a	NULL
calculated	NULL
molecular	NULL
mass	NULL
of	NULL
67	NULL
kilodaltons	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
has	NULL
been	NULL
detected	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
and	NULL
tissues	NULL
,	NULL
including	NULL
the	NULL
human	NULL
prostatic	NULL
carcinoma	NULL
cell	NULL
line	NULL
LNCaP	NULL
,	NULL
testis	NULL
,	NULL
ventral	NULL
prostate	NULL
,	NULL
and	NULL
seminal	NULL
vesical	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
HREs	NULL
for	NULL
steroid	NULL
hormone	NULL
receptors	NULL
are	NULL
structurally	NULL
related	NULL
but	NULL
functionally	NULL
distinct	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
finger	NULL
model	NULL
,	NULL
the	NULL
first	NULL
zinc	NULL
finger	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
steroid	NULL
hormone	NULL
receptors	NULL
may	NULL
determine	NULL
target	NULL
HRE	NULL
specificity	NULL
.	NULL

The	NULL
three	NULL
amino	NULL
acids	NULL
at	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
the	NULL
first	NULL
zinc	NULL
finger	NULL
are	NULL
categorized	NULL
as	NULL
the	NULL
P	NULL
(	NULL
proximal	NULL
)	NULL
box	NULL
,	NULL
which	NULL
is	NULL
important	NULL
in	NULL
base	NULL
interaction	NULL
.	NULL

Consequently	NULL
,	NULL
HREs	NULL
can	NULL
be	NULL
classified	NULL
into	NULL
two	NULL
main	NULL
categories	NULL
of	NULL
repeat	NULL
consensus	NULL
sequences	NULL
based	NULL
on	NULL
the	NULL
P	NULL
box	NULL
,	NULL
the	NULL
response	NULL
element	NULL
for	NULL
glucocorticoid	NULL
receptor	NULL
and	NULL
estrogen	NULL
receptor	NULL
(	NULL
ERE	NULL
)	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
glucocorticoid	NULL
response	NULL
element	NULL
group	NULL
,	NULL
which	NULL
includes	NULL
glucocorticoid	NULL
receptor	NULL
,	NULL
AR	NULL
,	NULL
progesterone	NULL
receptor	NULL
,	NULL
and	NULL
mineralocorticoid	NULL
receptor	NULL
,	NULL
recognizes	NULL
AGAACA	NULL
core	NULL
consensus	NULL
half-site	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
ERE	NULL
group	NULL
,	NULL
which	NULL
includes	NULL
estrogen	NULL
receptor	NULL
,	NULL
T	NULL
;	NULL
R	NULL
,	NULL
VDR	NULL
,	NULL
RAR	NULL
,	NULL
RXR	NULL
,	NULL
and	NULL
many	NULL
orphan	NULL
receptors	NULL
,	NULL
recognizes	NULL
AGGTCA	NULL
half-site	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
five	NULL
amino	NULL
acids	NULL
localized	NULL
in	NULL
the	NULL
second	NULL
zinc	NULL
finger	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
D	NULL
(	NULL
distal	NULL
)	NULL
box	NULL
,	NULL
which	NULL
is	NULL
important	NULL
in	NULL
dimerization	NULL
contact	NULL
forming	NULL
,	NULL
are	NULL
involved	NULL
in	NULL
half-HRE	NULL
spacing	NULL
functional	NULL
discrimination	NULL
.	NULL

These	NULL
two	NULL
structural	NULL
determinants	NULL
(	NULL
P	NULL
and	NULL
D	NULL
boxes	NULL
)	NULL
of	NULL
target	NULL
gene	NULL
specificity	NULL
may	NULL
suggest	NULL
a	NULL
pathway	NULL
for	NULL
the	NULL
coevolution	NULL
of	NULL
receptor	NULL
DNA-binding	NULL
domains	NULL
and	NULL
regulatory	NULL
gene	NULL
networks	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
P	NULL
and	NULL
D	NULL
box	NULL
sequences	NULL
,	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
is	NULL
assigned	NULL
to	NULL
the	NULL
ERE	NULL
subfamily	NULL
and	NULL
predicted	NULL
to	NULL
bind	NULL
to	NULL
an	NULL
AGGTCA	NULL
repeat	NULL
.	NULL

Recently	NULL
,	NULL
several	NULL
transcriptional	NULL
factors	NULL
from	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extracts	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
transcriptional	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
major	NULL
late	NULL
promoter	NULL
(	NULL
SV40-MLP	NULL
)	NULL
.	NULL

One	NULL
of	NULL
these	NULL
factors	NULL
turned	NULL
out	NULL
to	NULL
be	NULL
the	NULL
hERR1	NULL
orphan	NULL
receptor	NULL
(	NULL
6	NULL
,	NULL
10	NULL
)	NULL
.	NULL

One	NULL
of	NULL
the	NULL
core	NULL
sequences	NULL
within	NULL
the	NULL
SVA40-MLP	NULL
was	NULL
identified	NULL
as	NULL
AGGTCA	NULL
,	NULL
which	NULL
could	NULL
be	NULL
a	NULL
potential	NULL
HRE	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
developed	NULL
several	NULL
strategies	NULL
to	NULL
test	NULL
this	NULL
hypothesis	NULL
.	NULL

Herein	NULL
this	NULL
paper	NULL
is	NULL
the	NULL
summary	NULL
of	NULL
our	NULL
results	NULL
showing	NULL
the	NULL
TR2RE	NULL
within	NULL
SV40-MLP	NULL
as	NULL
the	NULL
first	NULL
identified	NULL
natural	NULL
HRE	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

5434	NULL
TR2RE	NULL
in	NULL
the	NULL
SV40-MLP	NULL
SP6	NULL
pSPUTK-TR2	NULL
5.17	NULL
Kb	NULL
TR2	NULL
1	NULL
2	NULL
3	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Analysis	NULL
of	NULL
in	NULL
vitro	NULL
expression	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
structure	NULL
of	NULL
a	NULL
high	NULL
level	NULL
in	NULL
vitro	NULL
expression	NULL
plasmid	NULL
pSPUTK-TR2	NULL
.	NULL

The	NULL
full-length	NULL
coding	NULL
sequence	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
cDNA	NULL
was	NULL
constructed	NULL
into	NULL
pSPUTK	NULL
vector	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
SP6	NULL
promoter	NULL
with	NULL
a	NULL
5'-untranslated	NULL
region	NULL
of	NULL
the	NULL
Xenopus	NULL
B-globin	NULL
gene	NULL
and	NULL
the	NULL
consensus	NULL
Kozak	NULL
translational	NULL
initiation	NULL
site	NULL
(	NULL
UTK	NULL
)	NULL
.	NULL

B	NULL
,	NULL
analysis	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
TR2	NULL
orphan	NULL
receptor	NULL
by	NULL
SDS-12	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Lane	NULL
1	NULL
displays	NULL
'*C-methylated	NULL
protein	NULL
standards	NULL
.	NULL

The	NULL
mock-translated	NULL
product	NULL
and	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
expressed	NULL
in	NULL
a	NULL
coupled	NULL
in	NULL
vitro	NULL
transcription-translation	NULL
system	NULL
are	NULL
shown	NULL
in	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
expected	NULL
molecular	NULL
mass	NULL
of	NULL
67	NULL
kilodaltons	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
is	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-TNT	NULL
SP6-coupled	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
was	NULL
purchased	NULL
from	NULL
Promega	NULL
.	NULL

L-	NULL
[	NULL
*°S	NULL
)	NULL
methionine	NULL
,	NULL
[	NULL
'*CJchloramphenicol	NULL
,	NULL
and	NULL
'*C-methylated	NULL
protein	NULL
standards	NULL
were	NULL
obtained	NULL
from	NULL
Amersham	NULL
Corp.	NULL
[	NULL
y-°°PJATP	NULL
was	NULL
from	NULL
DuPont	NULL
NEN	NULL
.	NULL

Acetyl	NULL
coenzyme	NULL
A	NULL
and	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
:	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Pharmacia	NULL
Biotech	NULL
Inc	NULL
.	NULL

Synthetic	NULL
oligonucleotides	NULL
were	NULL
either	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
J.	NULL
E.	NULL
Mertz	NULL
or	NULL
made	NULL
by	NULL
Bio-Synthesis	NULL
Inc.	NULL
(	NULL
Lewisville	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

Restriction	NULL
enzymes	NULL
and	NULL
other	NULL
modifying	NULL
enzymes	NULL
were	NULL
mainly	NULL
obtained	NULL
from	NULL
New	NULL
England	NULL
BioLabs	NULL
and	NULL
Promega	NULL
.	NULL

Plasmid	NULL
Construction-All	NULL
plasmids	NULL
were	NULL
constructed	NULL
by	NULL
standard	NULL
recombinant	NULL
DNA	NULL
techniques	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Plasmid	NULL
pSPUTK-TR2	NULL
contains	NULL
the	NULL
full-length	NULL
coding	NULL
sequence	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
cDNA	NULL
with	NULL
Xenopus	NULL
-globin	NULL
gene	NULL
5'-untranslated	NULL
region	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
SP6	NULL
promoter	NULL
in	NULL
the	NULL
pSPUTK	NULL
vector	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

Plasmid	NULL
pSG5-TR2	NULL
constitutes	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
cDNA	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
in	NULL
the	NULL
pSGS	NULL
vector	NULL
(	NULL
Stratagene	NULL
)	NULL
for	NULL
transient	NULL
transfection	NULL
experiments	NULL
.	NULL

Plasmid	NULL
pBL-SVL-CAT	NULL
consists	NULL
of	NULL
the	NULL
SV40	NULL
late	NULL
promoter	NULL
without	NULL
the	NULL
TR2RE	NULL
region	NULL
(	NULL
SV40	NULL
nucleotides	NULL
372-385	NULL
)	NULL
derived	NULL
from	NULL
pSVL-GR	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Mizokami	NULL
)	NULL
in	NULL
the	NULL
pBLCAT3	NULL
vector	NULL
(	NULL
12	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
plasmid	NULL
pBL-SVLRE-CAT	NULL
contains	NULL
the	NULL
SV40	NULL
late	NULL
promoter	NULL
with	NULL
the	NULL
TRZRE	NULL
region	NULL
and	NULL
intron	NULL
of	NULL
major	NULL
capsid	NULL
protein	NULL
VP1	NULL
derived	NULL
from	NULL
pSVL	NULL
(	NULL
Pharmacia	NULL
)	NULL
in	NULL
the	NULL
pBLCAT3	NULL
.	NULL

Plasmids	NULL
pSV55wt1	NULL
and	NULL
pSV55mut1	NULL
contain	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
wild-type	NULL
TR2RE	NULL
(	NULL
SV40	NULL
nucleotides	NULL
368-389	NULL
,	NULL
5435	NULL
Protein	NULL
:	NULL
-	NULL
-	NULL
TR2	NULL
TRZ2	NULL
TR2	NULL
TR3	NULL
Probe	NULL
:	NULL
+	NULL
+o	NULL
0+	NULL
+	NULL
+	NULL
Competitor	NULL
:	NULL
-	NULL
-	NULL
_	NULL
wt	NULL
mut	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
to	NULL
+55	NULL
region	NULL
of	NULL
the	NULL
SV40-MLP	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
with	NULL
in	NULL
vitro	NULL
expressed	NULL
TR2	NULL
orphan	NULL
receptor	NULL
and	NULL
the	NULL
*°P-labeled	NULL
probe	NULL
corresponding	NULL
to	NULL
SV40	NULL
nucleotides	NULL
368-389	NULL
(	NULL
see	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
shows	NULL
the	NULL
probe	NULL
alone	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
incubated	NULL
with	NULL
in	NULL
vitro	NULL
synthesized	NULL
TR2	NULL
orphan	NULL
receptor	NULL
and	NULL
the	NULL
probe	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100-fold	NULL
molar	NULL
excesses	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
w¢	NULL
)	NULL
oligonucleotides	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
mut	NULL
)	NULL
oligonucleotides	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
are	NULL
shown	NULL
.	NULL

Lane	NULL
5	NULL
displays	NULL
binding	NULL
reaction	NULL
mixtures	NULL
incubated	NULL
with	NULL
in	NULL
vitro	NULL
expressed	NULL
TR3	NULL
orphan	NULL
receptor	NULL
and	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
retarded	NULL
complex	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrowhead	NULL
,	NULL
while	NULL
nonspecific	NULL
complexes	NULL
appear	NULL
between	NULL
the	NULL
retarded	NULL
complex	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

GTCATGGA-3	NULL
'	NULL
)	NULL
and	NULL
the	NULL
mutant	NULL
TRZRE	NULL
(	NULL
SV40	NULL
nucleotides	NULL
367-389	NULL
,	NULL
5'-CGTTAAGCTTCGTAGCTCATGGA-3	NULL
'	NULL
)	NULL
in	NULL
the	NULL
blunted	NULL
Bg/II	NULL
site	NULL
of	NULL
the	NULL
pCAT-promoter	NULL
plasmid	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Plasmid	NULL
pCMV-AR	NULL
contains	NULL
the	NULL
full-length	NULL
AR	NULL
cDNA	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
promoter	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Chimeric	NULL
AR/TR2/AR	NULL
plasmid	NULL
consists	NULL
of	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
flanked	NULL
by	NULL
the	NULL
N-terminal	NULL
and	NULL
androgen-binding	NULL
domains	NULL
of	NULL
AR	NULL
at	NULL
both	NULL
ends	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Plasmid	NULL
pMSG-CAT	NULL
contains	NULL
the	NULL
full-length	NULL
mouse	NULL
mammary	NULL
tumor	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
sequence	NULL
linked	NULL
with	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Coupled	NULL
in	NULL
Vitro	NULL
Transcription	NULL
and	NULL
Translation-Circular	NULL
pSPUTK-TR2	NULL
plasmid	NULL
containing	NULL
the	NULL
full-length	NULL
TR2	NULL
orphan	NULL
receptor	NULL
cDNA	NULL
was	NULL
in	NULL
vitro	NULL
transcribed	NULL
and	NULL
translated	NULL
simultaneously	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Depending	NULL
on	NULL
the	NULL
purpose	NULL
of	NULL
the	NULL
experiment	NULL
,	NULL
the	NULL
reactions	NULL
were	NULL
performed	NULL
either	NULL
with	NULL
or	NULL
without	NULL
[	NULL
*°S	NULL
)	NULL
methionine	NULL
in	NULL
the	NULL
transcription-translation	NULL
mixture	NULL
.	NULL

After	NULL
synthesis	NULL
,	NULL
ZnCl	NULL
,	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.5	NULL
mm	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
translated	NULL
products	NULL
were	NULL
then	NULL
analyzed	NULL
directly	NULL
by	NULL
either	NULL
electrophoresis	NULL
in	NULL
SDS-12	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
or	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Plasmid	NULL
pSGS5-TR3	NULL
was	NULL
used	NULL
to	NULL
express	NULL
the	NULL
TR3	NULL
orphan	NULL
receptor	NULL
under	NULL
control	NULL
of	NULL
T7	NULL
promoter	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
in	NULL
EMSA	NULL
.	NULL

DNA-Protein	NULL
Binding	NULL
Assay-DNA-protein	NULL
binding	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

*°P-Labeled	NULL
oligonucleotides	NULL
(	NULL
0.01-0.2	NULL
ng	NULL
,	NULL
2	NULL
x	NULL
10	NULL
``	NULL
cpm	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
varying	NULL
ratios	NULL
(	NULL
2-200	NULL
ng	NULL
)	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
TR2	NULL
orphan	NULL
receptor	NULL
protein	NULL
and	NULL
followed	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
optimum	NULL
concentration	NULL
of	NULL
protein	NULL
was	NULL
determined	NULL
and	NULL
fixed	NULL
(	NULL
60	NULL
ng	NULL
)	NULL
.	NULL

For	NULL
Scatchard	NULL
analysis	NULL
,	NULL
constant	NULL
amounts	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
TR2	NULL
orphan	NULL
receptor	NULL
were	NULL
incubated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
the	NULL
TR2RE	NULL
probe	NULL
(	NULL
0.002-1.5	NULL
ng	NULL
)	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
free	NULL
probe	NULL
and	NULL
retarded	NULL
band	NULL
were	NULL
quantified	NULL
by	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

The	NULL
dissociation	NULL
constant	NULL
(	NULL
K	NULL
,	NULL
,	NULL
)	NULL
value	NULL
was	NULL
determined	NULL
from	NULL
the	NULL
minus	NULL
reciprocal	NULL
of	NULL
the	NULL
slope	NULL
of	NULL
the	NULL
line	NULL
generated	NULL
from	NULL
the	NULL
empirical	NULL
data	NULL
.	NULL

EMSA-EMSA	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
17	NULL
)	NULL
with	NULL
some	NULL
modification	NULL
.	NULL

Double-stranded	NULL
TRZ2RE	NULL
primers	NULL
corresponding	NULL
to	NULL
SV40	NULL
nucleotides	NULL
368-389	NULL
(	NULL
5'-GTTAAGGTTCGTAGGTCATGGA-3	NULL
'	NULL
)	NULL
were	NULL
end-labeled	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

4	NULL
wl	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
TR2	NULL
orphan	NULL
5436	NULL
SVA4O	NULL
Major	NULL
Late	NULL
Initiation	NULL
Site	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Schematic	NULL
structure	NULL
of	NULL
the	NULL
TRZRE	NULL
among	NULL
the	NULL
transcriptional	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
SV40-MLP	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
transcriptional	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
SV40-MLP	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
either	NULL
the	NULL
wild-type	NULL
or	NULL
mutant	NULL
TRZ2RE	NULL
,	NULL
an	NULL
imperfect	NULL
direct	NULL
ree	NULL
_	NULL
359	NULL
peat	NULL
of	NULL
the	NULL
AGGTCA	NULL
half-site	NULL
,	NULL
is	NULL
boxed	NULL
.	NULL

The	NULL
TR2RE	NULL
is	NULL
located	NULL
at	NULL
the	NULL
+55	NULL
region	NULL
of	NULL
the	NULL
major	NULL
late	NULL
transcript	NULL
.	NULL

Numbers	NULL
under	NULL
the	NULL
sequence	NULL
show	NULL
SV40	NULL
nucleotide	NULL
residues	NULL
(	NULL
19	NULL
)	NULL
.	NULL

AGG	NULL
0.03	NULL
g	NULL
Kd=9	NULL
nM	NULL
0.025	NULL
-	NULL
Bmax=0.3	NULL
nM	NULL
0.02	NULL
<	NULL
8	NULL
5	NULL
0.015	NULL
-	NULL
a	NULL
3	NULL
0	NULL
ma	NULL
0.01	NULL
7	NULL
0.005	NULL
<	NULL
[	NULL
=|	NULL
0	NULL
L	NULL
I	NULL
1	NULL
``	NULL
P	NULL
0.05	NULL
0.1	NULL
0.15	NULL
0.2	NULL
0.25	NULL
0.3	NULL
Bound	NULL
(	NULL
nM	NULL
)	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Binding	NULL
affinity	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
to	NULL
the	NULL
TRZRE	NULL
.	NULL

Constant	NULL
amounts	NULL
of	NULL
in	NULL
vitro	NULL
expressed	NULL
TR2	NULL
orphan	NULL
receptor	NULL
were	NULL
used	NULL
in	NULL
a	NULL
series	NULL
of	NULL
EMSAs	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
*°P-labeled	NULL
TR2RE	NULL
.	NULL

The	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
were	NULL
quantified	NULL
by	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

We	NULL
plotted	NULL
the	NULL
ratio	NULL
between	NULL
TR2-bound	NULL
(	NULL
nm	NULL
)	NULL
and	NULL
free	NULL
DNA	NULL
with	NULL
respect	NULL
to	NULL
TR2-bound	NULL
DNA	NULL
.	NULL

The	NULL
dissociation	NULL
constant	NULL
(	NULL
K	NULL
,	NULL
,	NULL
)	NULL
value	NULL
was	NULL
determined	NULL
from	NULL
the	NULL
minus	NULL
reciprocal	NULL
of	NULL
the	NULL
slope	NULL
of	NULL
the	NULL
line	NULL
generated	NULL
from	NULL
the	NULL
experimental	NULL
data	NULL
.	NULL

A	NULL
Scatchard	NULL
plot	NULL
of	NULL
the	NULL
results	NULL
is	NULL
shown	NULL
.	NULL

receptor	NULL
protein	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
probe	NULL
(	NULL
0.02-0.1	NULL
ng	NULL
,	NULL
10°	NULL
cpm	NULL
)	NULL
in	NULL
the	NULL
EMSA	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
100	NULL
mm	NULL
KCl	NULL
,	NULL
1	NULL
mx	NULL
dithiothreitol	NULL
,	NULL
0.05	NULL
mM	NULL
EDTA	NULL
,	NULL
2.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
6	NULL
%	NULL
glycerol	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
-poly	NULL
(	NULL
dI-dC	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
resulting	NULL
complexes	NULL
were	NULL
then	NULL
separated	NULL
on	NULL
a	NULL
native	NULL
6	NULL
%	NULL
polyacrylamide	NULL
(	NULL
37:1	NULL
)	NULL
gel	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
0.5	NULL
x	NULL
TBE	NULL
(	NULL
1	NULL
x	NULL
TBE	NULL
=	NULL
50	NULL
mM	NULL
Tris	NULL
base	NULL
,	NULL
50	NULL
mM	NULL
borie	NULL
acid	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
8.3	NULL
)	NULL
at	NULL
10	NULL
V/em	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
gel	NULL
retardation	NULL
was	NULL
either	NULL
visualized	NULL
by	NULL
autoradiogra-phy	NULL
or	NULL
quantified	NULL
by	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
,	NULL
Transfection	NULL
,	NULL
and	NULL
CAT	NULL
Assay-HeLa	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
an	NULL
initial	NULL
density	NULL
of	NULL
3	NULL
x	NULL
10°	NULL
%	NULL
/60-mm	NULL
dish	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
nutrient	NULL
mixture	NULL
(	NULL
DMEM/F-12	NULL
)	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
or	NULL
5	NULL
%	NULL
charcoal-treated	NULL
FBS	NULL
(	NULL
CTS	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
the	NULL
HeLa	NULL
cells	NULL
with	NULL
plasmid	NULL
DNA	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
a	NULL
calcium	NULL
phosphate-DNA	NULL
precipitation	NULL
method	NULL
(	NULL
18	NULL
)	NULL
.	NULL

To	NULL
normalize	NULL
the	NULL
transfection	NULL
efficiency	NULL
,	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus-based	NULL
B-galactosidase	NULL
expression	NULL
plasmid	NULL
galactosidase	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
K.	NULL
Verma	NULL
)	NULL
was	NULL
cotransfected	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
both	NULL
B-galactosidase	NULL
and	NULL
CAT	NULL
activities	NULL
at	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Each	NULL
value	NULL
of	NULL
CAT	NULL
conversion	NULL
represents	NULL
the	NULL
mean	NULL
*	NULL
S.D	NULL
.	NULL

from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

RESULTS	NULL
In	NULL
Vitro	NULL
Expression	NULL
of	NULL
TR2	NULL
Orphan	NULL
Receptor-There	NULL
are	NULL
at	NULL
least	NULL
three	NULL
binding	NULL
sites	NULL
of	NULL
nuclear	NULL
proteins	NULL
within	NULL
the	NULL
transcriptional	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
SV40-MLP	NULL
(	NULL
10	NULL
)	NULL
.	NULL

One	NULL
of	NULL
these	NULL
initiator-binding	NULL
sites	NULL
consists	NULL
of	NULL
core	NULL
consensus	NULL
AGGTCA	NULL
half	NULL
ATTT	NULL
CAGGCCATGGTGCTGCGCCGGCTGT	NULL
CACGCCAGGCCTCCGTTA	NULL
m	NULL
T	NULL
W	NULL
A	NULL
TCCAATAAAGTCCGGTACCACGACGCGGCC	NULL
?	NULL

ACAGTGCGGTCCGGAGGCAA	NULL
AAGICA	NULL
AGT	NULL
AC	NULL
TR2RE	NULL
in	NULL
the	NULL
SV40-MLP	NULL
CT	NULL
350	NULL
380	NULL
.	NULL

[	NULL
AGerrelethkGcrca	NULL
Mutant	NULL
TRars	NULL
:	NULL
|AGCTTCCTACCICA	NULL
site	NULL
that	NULL
may	NULL
represent	NULL
the	NULL
potential	NULL
HRE	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
preliminary	NULL
data	NULL
also	NULL
suggested	NULL
that	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
HeLa	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
could	NULL
be	NULL
one	NULL
of	NULL
the	NULL
candidates	NULL
that	NULL
may	NULL
bind	NULL
to	NULL
this	NULL
region	NULL
and	NULL
play	NULL
some	NULL
role	NULL
in	NULL
SV40	NULL
gene	NULL
expression	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
prepared	NULL
in	NULL
vitro	NULL
translated	NULL
TR2	NULL
orphan	NULL
receptor	NULL
protein	NULL
for	NULL
EMSA	NULL
.	NULL

We	NULL
constructed	NULL
the	NULL
full-length	NULL
TR2	NULL
orphan	NULL
receptor	NULL
cDNA	NULL
into	NULL
pSPUTK	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
SP6	NULL
promoter	NULL
with	NULL
a	NULL
5'-untranslated	NULL
region	NULL
of	NULL
the	NULL
Xenopus	NULL
B-globin	NULL
gene	NULL
and	NULL
the	NULL
consensus	NULL
Kozak	NULL
translational	NULL
initiation	NULL
site	NULL
(	NULL
UTK	NULL
)	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

The	NULL
mock-translated	NULL
control	NULL
expressed	NULL
in	NULL
a	NULL
coupled	NULL
in	NULL
vitro	NULL
transcription-translation	NULL
system	NULL
produced	NULL
no	NULL
detectable	NULL
product	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
vitro	NULL
translation	NULL
of	NULL
pSPUTK-TRZ	NULL
yielded	NULL
a	NULL
protein	NULL
of	NULL
the	NULL
expected	NULL
molecular	NULL
mass	NULL
of	NULL
67	NULL
kilodaltons	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
minor	NULL
product	NULL
probably	NULL
arose	NULL
from	NULL
internal	NULL
initiation	NULL
of	NULL
translation	NULL
or	NULL
limited	NULL
degradation	NULL
.	NULL

TR2	NULL
Orphan	NULL
Receptor	NULL
Can	NULL
Bind	NULL
at	NULL
+55	NULL
Region	NULL
of	NULL
the	NULL
SV40-MLP-To	NULL
investigate	NULL
the	NULL
possible	NULL
interaction	NULL
of	NULL
authentic	NULL
TRZ	NULL
orphan	NULL
receptor	NULL
with	NULL
the	NULL
+55	NULL
region	NULL
of	NULL
the	NULL
SV40-MLP	NULL
,	NULL
we	NULL
performed	NULL
an	NULL
EMSA	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
in	NULL
this	NULL
study	NULL
was	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
SV40	NULL
nucleotide	NULL
numbers	NULL
368-389	NULL
(	NULL
5-GTTAAGGTTCGTAGGTCAT-GGA-3	NULL
'	NULL
)	NULL
(	NULL
19	NULL
)	NULL
.	NULL

A	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
was	NULL
visualized	NULL
in	NULL
the	NULL
EMSA	NULL
with	NULL
the	NULL
probe	NULL
and	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
protein	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
DNA-protein	NULL
complex	NULL
could	NULL
be	NULL
eliminated	NULL
upon	NULL
the	NULL
addition	NULL
of	NULL
100-fold	NULL
molar	NULL
excesses	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
DNA-protein	NULL
complex	NULL
remained	NULL
intact	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100-fold	NULL
molar	NULL
excesses	NULL
of	NULL
mutated	NULL
oligonucleotides	NULL
(	NULL
mutant	NULL
TR2RE	NULL
)	NULL
with	NULL
a	NULL
point	NULL
mutation	NULL
on	NULL
the	NULL
third	NULL
nucleotide	NULL
in	NULL
both	NULL
repeat	NULL
motifs	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
was	NULL
no	NULL
specific	NULL
interaction	NULL
between	NULL
these	NULL
oligonucleotides	NULL
(	NULL
TR2RE	NULL
)	NULL
and	NULL
the	NULL
in	NULL
vitro	NULL
expressed	NULL
TR3	NULL
orphan	NULL
receptor	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
another	NULL
orphan	NULL
receptor	NULL
identified	NULL
in	NULL
our	NULL
laboratory	NULL
,	NULL
or	NULL
a	NULL
mock-translated	NULL
product	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
indeed	NULL
had	NULL
the	NULL
ability	NULL
to	NULL
specifically	NULL
bind	NULL
to	NULL
the	NULL
TRZRE	NULL
,	NULL
but	NULL
not	NULL
to	NULL
mutant	NULL
TR2RE	NULL
,	NULL
in	NULL
the	NULL
SV40-MLP	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

TR2	NULL
Orphan	NULL
Receptor	NULL
Can	NULL
Bind	NULL
to	NULL
the	NULL
TR2RE	NULL
with	NULL
High	NULL
Affinity-To	NULL
examine	NULL
the	NULL
binding	NULL
affinity	NULL
between	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
and	NULL
the	NULL
TRZ2RE	NULL
in	NULL
more	NULL
detail	NULL
,	NULL
we	NULL
employed	NULL
Scatchard	NULL
binding	NULL
analysis	NULL
for	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
in	NULL
the	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Scatchard	NULL
plot	NULL
analysis	NULL
revealed	NULL
a	NULL
single	NULL
binding	NULL
component	NULL
for	NULL
this	NULL
DNA-protein	NULL
complex	NULL
with	NULL
a	NULL
dissociation	NULL
constant	NULL
(	NULL
K	NULL
,	NULL
,	NULL
)	NULL
of	NULL
9	NULL
nm	NULL
and	NULL
B.	NULL
,	NULL
,	NULL
,	NULL
,	NULL
of	NULL
0.3	NULL
nm	NULL
to	NULL
the	NULL
TR2RE	NULL
that	NULL
fit	NULL
the	NULL
range	NULL
of	NULL
K	NULL
,	NULL
,	NULL
for	NULL
steroid	NULL
receptors	NULL
and	NULL
their	NULL
HREs	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Ligand	NULL
Effect	NULL
on	NULL
the	NULL
Interaction	NULL
between	NULL
the	NULL
TR2RE	NULL
and	NULL
the	NULL
TR2	NULL
Orphan	NULL
Receptor-All	NULL
in	NULL
vitro	NULL
binding	NULL
data	NULL
suggested	NULL
that	NULL
TR2RE	NULL
could	NULL
be	NULL
the	NULL
potential	NULL
HRE	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

The	NULL
next	NULL
question	NULL
asked	NULL
was	NULL
whether	NULL
this	NULL
interaction	NULL
between	NULL
the	NULL
TRZRE	NULL
and	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
was	NULL
ligand	NULL
TR2RE	NULL
in	NULL
the	NULL
SV40-MLP	NULL
A	NULL
R	NULL
L	NULL
5437	NULL
S/H	NULL
X	NULL
R	NULL
o	NULL
14	NULL
R___S_	NULL
X	NULL
R	NULL
S_X	NULL
AR	NULL
TR2	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Confirmation	NULL
of	NULL
the	NULL
repressor	NULL
function	NULL
of	NULL
the	NULL
TRZ2RE	NULL
by	NULL
chi-	NULL
R	NULL
meric	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

A	NULL
,	NULL
scheme	NULL
AR/TRZ/AR	NULL
4	NULL
of	NULL
the	NULL
expression	NULL
plasmid	NULL
AR/TR2/AR	NULL
chi-mera	NULL
.	NULL

Chimeric	NULL
AR/TR2/AR	NULL
plasmid	NULL
contains	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
in	NULL
the	NULL
middle	NULL
flanked	NULL
by	NULL
the	NULL
N-terminal	NULL
and	NULL
androgen-binding	NULL
domains	NULL
of	NULL
AR	NULL
at	NULL
both	NULL
ends	NULL
in	NULL
the	NULL
pSG5	NULL
vector	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
AR	NULL
is	NULL
replaced	NULL
with	NULL
that	NULL
of	NULL
the	NULL
TRZ2	NULL
orphan	NULL
receptor	NULL
(	NULL
shaded	NULL
box	NULL
)	NULL
.	NULL

H	NULL
,	NULL
Hpal	NULL
;	NULL
R	NULL
,	NULL
EcoRI	NULL
;	NULL
S	NULL
,	NULL
Sacll	NULL
;	NULL
and	NULL
X	NULL
,	NULL
Xhol	NULL
.	NULL

B	NULL
,	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
cotransfected	NULL
with	NULL
chimeric	NULL
plasmid	NULL
and	NULL
different	NULL
reporter	NULL
plasmids	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
10	NULL
nM	NULL
synthetic	NULL
androgen	NULL
(	NULL
R1881	NULL
)	NULL
.	NULL

Both	NULL
pSV55wt1	NULL
and	NULL
pSV55mut1	NULL
reporter	NULL
plasmids	NULL
are	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
.	NULL

All	NULL
CAT	NULL
assays	NULL
were	NULL
normalized	NULL
for	NULL
the	NULL
level	NULL
of	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Each	NULL
value	NULL
represents	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
relative	NULL
folds	NULL
of	NULL
CAT	NULL
conversion	NULL
from	NULL
the	NULL
cotransfection	NULL
with	NULL
chimera	NULL
plasmid	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
or	NULL
positive	NULL
control	NULL
pCMV-AR	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
and	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
pSV55wt1	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
pSV55	NULL
mutl	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
or	NULL
pMSG-CAT	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
nM	NULL
R1881	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
done	NULL
in	NULL
CTS	NULL
during	NULL
cell	NULL
culture	NULL
.	NULL

B	NULL
dependent	NULL
.	NULL

Unlike	NULL
classic	NULL
members	NULL
of	NULL
the	NULL
steroid-thyroid	NULL
hormone	NULL
receptors	NULL
,	NULL
which	NULL
have	NULL
their	NULL
own	NULL
ligands	NULL
to	NULL
test	NULL
the	NULL
ligand	NULL
dependence	NULL
,	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
is	NULL
a	NULL
receptor	NULL
without	NULL
a	NULL
known	NULL
ligand	NULL
.	NULL

To	NULL
overcome	NULL
this	NULL
problem	NULL
,	NULL
we	NULL
developed	NULL
a	NULL
``	NULL
DNA	NULL
swap	NULL
``	NULL
strategy	NULL
to	NULL
test	NULL
this	NULL
hypothesis	NULL
.	NULL

A	NULL
chimeric	NULL
receptor	NULL
,	NULL
AR/TR2/AR	NULL
,	NULL
with	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
flanked	NULL
by	NULL
the	NULL
N-terminal	NULL
and	NULL
androgen-binding	NULL
domains	NULL
of	NULL
the	NULL
AR	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
was	NULL
created	NULL
here	NULL
to	NULL
study	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
TR2RE	NULL
and	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

This	NULL
chimeric	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
into	NULL
HeLa	NULL
cells	NULL
with	NULL
reporter	NULL
plasmids	NULL
,	NULL
which	NULL
consist	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
regulated	NULL
by	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
containing	NULL
either	NULL
the	NULL
TR2RE	NULL
or	NULL
mutant	NULL
TRZ2RE	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
by	NULL
androgen	NULL
was	NULL
then	NULL
tested	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
androgen	NULL
clearly	NULL
suppressed	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
via	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
and	NULL
the	NULL
TR2RE	NULL
.	NULL

However	NULL
,	NULL
SV40	NULL
early	NULL
promoter	NULL
construct	NULL
with	NULL
a	NULL
mutant	NULL
TR2RE	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
androgen	NULL
in	NULL
similar	NULL
transient	NULL
transfection	NULL
CAT	NULL
assay	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
demonstrated	NULL
that	NULL
ligand	NULL
can	NULL
affect	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
TR2RE	NULL
and	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
and	NULL
further	NULL
confirmed	NULL
the	NULL
TR2RE	NULL
is	NULL
the	NULL
HRE	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

TR2	NULL
Orphan	NULL
Receptor	NULL
Suppresses	NULL
the	NULL
Transcriptional	NULL
Activity	NULL
of	NULL
the	NULL
SV40-MLP	NULL
via	NULL
the	NULL
TR2RE-Thus	NULL
far	NULL
,	NULL
all	NULL
of	NULL
our	NULL
Expression	NULL
:	NULL
Reporter	NULL
:	NULL
10	NULL
nM	NULL
R1881	NULL
:	NULL
Fold	NULL
of	NULL
CAT	NULL
Conversion	NULL
AR/TR2/AR	NULL
AR/TR2/AR	NULL
pCMV-AR	NULL
pSV55wtl	NULL
pSV55mut1l	NULL
pMSG-CAT	NULL
+	NULL
-	NULL
+	NULL
+	NULL
250	NULL
200	NULL
150	NULL
4	NULL
50	NULL
data	NULL
have	NULL
supported	NULL
the	NULL
idea	NULL
that	NULL
SV40-MLP	NULL
contains	NULL
the	NULL
TR2RE	NULL
,	NULL
a	NULL
potential	NULL
HRE	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

We	NULL
then	NULL
determined	NULL
if	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
directly	NULL
can	NULL
play	NULL
any	NULL
role	NULL
in	NULL
SV40	NULL
gene	NULL
expression	NULL
via	NULL
interaction	NULL
with	NULL
the	NULL
TR2RE	NULL
.	NULL

CAT	NULL
assay	NULL
with	NULL
the	NULL
cotransfection	NULL
of	NULL
mammalian	NULL
expression	NULL
vector	NULL
containing	NULL
the	NULL
full-length	NULL
TR2	NULL
orphan	NULL
receptor	NULL
cDNA	NULL
(	NULL
pSG5-TR2	NULL
)	NULL
and	NULL
either	NULL
pBL-SVL-CAT	NULL
(	NULL
without	NULL
the	NULL
TR2RE	NULL
)	NULL
or	NULL
pBL-SVLRE-CAT	NULL
(	NULL
with	NULL
the	NULL
TR2RE	NULL
)	NULL
reporter	NULL
into	NULL
HeLa	NULL
cells	NULL
indicated	NULL
that	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
can	NULL
not	NULL
affect	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
SV40-MLP	NULL
without	NULL
the	NULL
TR2RE	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
can	NULL
suppress	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
SV40-MLP	NULL
containing	NULL
the	NULL
TR2RE	NULL
region	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggested	NULL
that	NULL
this	NULL
TR2RE	NULL
may	NULL
function	NULL
as	NULL
a	NULL
repressor	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
SV40-MLP	NULL
.	NULL

Suppression	NULL
of	NULL
SV40-MLP	NULL
Gene	NULL
Expression	NULL
Is	NULL
Activator	NULL
Dependent-As	NULL
our	NULL
data	NULL
demonstrated	NULL
that	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
may	NULL
function	NULL
as	NULL
a	NULL
repressor	NULL
for	NULL
the	NULL
SV40	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
then	NULL
attempted	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
always	NULL
binds	NULL
to	NULL
the	NULL
TRZRE	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
constitutively	NULL
blocks	NULL
the	NULL
SV40	NULL
gene	NULL
expression	NULL
or	NULL
if	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
needs	NULL
activator	NULL
(	NULL
s	NULL
)	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
its	NULL
supression	NULL
function	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
applied	NULL
regular	NULL
FBS	NULL
versus	NULL
CTS	NULL
in	NULL
the	NULL
transient	NULL
transfection	NULL
CAT	NULL
assay	NULL
.	NULL

Our	NULL
assumption	NULL
was	NULL
5438	NULL
A	NULL
TR2RE	NULL
in	NULL
the	NULL
SV40-MLP	NULL
SV40	NULL
Late	NULL
-	NULL
Promoter	NULL
|-	NULL
_	NULL
CAT	NULL
pBL-SVL-CAT	NULL
(	NULL
a	NULL
)	NULL
w/o	NULL
TR2RE	NULL
--	NULL
-	NULL
Promoter	NULL
YPI	NULL
Intron	NULL
--	NULL
-	NULL
CAT	NULL
pBL-SVLRE-	NULL
(	NULL
b	NULL
)	NULL
w/	NULL
TR2RE	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Suppression	NULL
of	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
SV40-MLP	NULL
via	NULL
the	NULL
TR2RE	NULL
.	NULL

A	NULL
,	NULL
scheme	NULL
of	NULL
two	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
.	NULL

While	NULL
pBL-SVL-CAT	NULL
plasmid	NULL
(	NULL
a	NULL
)	NULL
consists	NULL
B	NULL
of	NULL
the	NULL
SV40	NULL
late	NULL
promoter	NULL
without	NULL
the	NULL
TR2RE	NULL
,	NULL
pBL-SVLRE-CAT	NULL
plasmid	NULL
(	NULL
6	NULL
)	NULL
contains	NULL
the	NULL
SV40	NULL
late	NULL
promoter	NULL
with	NULL
the	NULL
TR2RE	NULL
and	NULL
intron	NULL
of	NULL
major	NULL
capsid	NULL
protein	NULL
VP1	NULL
followed	NULL
by	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

B	NULL
,	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
expression	NULL
plasmid	NULL
pSG5-TR2	NULL
and	NULL
two	NULL
different	NULL
reporter	NULL
plasmids	NULL
.	NULL

All	NULL
CAT	NULL
assays	NULL
were	NULL
normalized	NULL
for	NULL
the	NULL
level	NULL
of	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Each	NULL
value	NULL
represents	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
relative	NULL
folds	NULL
of	NULL
CAT	NULL
conversion	NULL
from	NULL
the	NULL
cotransfection	NULL
with	NULL
pSG5-TR2	NULL
and	NULL
either	NULL
pBL-SVL-CAT	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
pBL-SVLRE-CAT	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

that	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
may	NULL
have	NULL
some	NULL
activator	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
serum	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
the	NULL
repressor	NULL
function	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
potential	NULL
activator	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
serum	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
charcoal-treated	NULL
serum	NULL
can	NULL
abolish	NULL
such	NULL
suppression	NULL
by	NULL
the	NULL
removal	NULL
of	NULL
the	NULL
potential	NULL
TR2	NULL
activator	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
serum	NULL
.	NULL

These	NULL
results	NULL
further	NULL
suggested	NULL
that	NULL
such	NULL
activator-dependent	NULL
suppression	NULL
of	NULL
the	NULL
SV40	NULL
gene	NULL
expression	NULL
may	NULL
rely	NULL
on	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
TR2RE	NULL
and	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
mutant	NULL
TRZ2RE	NULL
had	NULL
no	NULL
influence	NULL
on	NULL
the	NULL
suppression	NULL
of	NULL
the	NULL
SV40	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
FBS	NULL
or	NULL
CTS	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
strongly	NULL
suggested	NULL
that	NULL
the	NULL
TR2RE	NULL
is	NULL
a	NULL
HRE	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
and	NULL
functions	NULL
as	NULL
a	NULL
repressor	NULL
in	NULL
the	NULL
SV40	NULL
gene	NULL
expression	NULL
in	NULL
an	NULL
activator-dependent	NULL
manner	NULL
.	NULL

DISCUSSION	NULL
It	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
that	NULL
some	NULL
orphan	NULL
receptors	NULL
may	NULL
affect	NULL
the	NULL
expression	NULL
of	NULL
viruses	NULL
.	NULL

For	NULL
example	NULL
,	NULL
chicken	NULL
ovalbumin	NULL
upstream	NULL
promoter	NULL
transcription	NULL
factor	NULL
can	NULL
bind	NULL
to	NULL
a	NULL
negative	NULL
regulatory	NULL
region	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Hepatitis	NULL
B	NULL
virus	NULL
enhancer	NULL
I	NULL
contains	NULL
response	NULL
elements	NULL
of	NULL
enhancer	NULL
binding	NULL
factor	NULL
to	NULL
polyoma	NULL
C	NULL
,	NULL
hepatocyte	NULL
nuclear	NULL
factor	NULL
4	NULL
,	NULL
and	NULL
retinoid	NULL
X	NULL
receptor	NULL
(	NULL
RXR	NULL
,	NULL
,	NULL
)	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
TR3	NULL
orphan	NULL
receptor	NULL
and	NULL
nuclear	NULL
factor	NULL
I	NULL
can	NULL
induce	NULL
transcription	NULL
of	NULL
the	NULL
mouse	NULL
mammary	NULL
tumor	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
14	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
hERR1	NULL
and	NULL
other	NULL
orphan	NULL
receptors	NULL
have	NULL
also	NULL
been	NULL
suggested	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
transcriptional	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
SV40-MLP	NULL
that	NULL
may	NULL
be	NULL
in	NULL
pSGS-TR2	NULL
:	NULL
*	NULL
+	NULL
Reporter	NULL
:	NULL
a	NULL
-_	NULL
b	NULL
We	NULL
2.5	NULL
g	NULL
27	NULL
R+	NULL
e	NULL
2	NULL
g	NULL
1.3	NULL
~	NULL
2	NULL
O	NULL
E	NULL
bust	NULL
O	NULL
1	NULL
7	NULL
G	NULL
s	NULL
k	NULL
6	NULL
HL	NULL
0.5	NULL
-	NULL
]	NULL
o	NULL
1	NULL
2	NULL
volved	NULL
in	NULL
the	NULL
early-to-late	NULL
shift	NULL
in	NULL
the	NULL
SV40	NULL
gene	NULL
expression	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
can	NULL
bind	NULL
to	NULL
a	NULL
negative	NULL
response	NULL
element	NULL
in	NULL
the	NULL
transcriptional	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
SV40-MLP	NULL
will	NULL
further	NULL
expand	NULL
the	NULL
knowledge	NULL
of	NULL
the	NULL
influence	NULL
of	NULL
orphan	NULL
receptors	NULL
on	NULL
the	NULL
gene	NULL
expression	NULL
of	NULL
viruses	NULL
.	NULL

The	NULL
AGGTCA	NULL
motif	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
the	NULL
primary	NULL
target	NULL
element	NULL
for	NULL
the	NULL
members	NULL
of	NULL
the	NULL
ERE	NULL
subfamily	NULL
in	NULL
the	NULL
steroid-thyroid	NULL
hormone	NULL
receptor	NULL
superfamily	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Many	NULL
family	NULL
members	NULL
,	NULL
including	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
identified	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
can	NULL
bind	NULL
to	NULL
this	NULL
core	NULL
sequence	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
yet	NULL
how	NULL
distinct	NULL
sets	NULL
of	NULL
target	NULL
genes	NULL
are	NULL
regulated	NULL
by	NULL
these	NULL
nuclear	NULL
receptors	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
primary	NULL
sequence	NULL
,	NULL
recent	NULL
evidence	NULL
has	NULL
suggested	NULL
that	NULL
the	NULL
orientation	NULL
and	NULL
spacing	NULL
of	NULL
repeat	NULL
core	NULL
elements	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
hormonal	NULL
regulation	NULL
of	NULL
these	NULL
receptors	NULL
(	NULL
Ref	NULL
.	NULL

23	NULL
;	NULL
also	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

24	NULL
for	NULL
review	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
a	NULL
novel	NULL
cooperative	NULL
dimer	NULL
interaction	NULL
within	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
family	NULL
members	NULL
has	NULL
been	NULL
proposed	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

A	NULL
region	NULL
in	NULL
the	NULL
first	NULL
zinc	NULL
finger	NULL
of	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
T	NULL
;	NULL
R	NULL
or	NULL
RAR	NULL
can	NULL
interact	NULL
with	NULL
the	NULL
second	NULL
zinc	NULL
finger	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
RXR	NULL
to	NULL
promote	NULL
selective	NULL
DNA	NULL
binding	NULL
to	NULL
direct	NULL
repeats	NULL
spaced	NULL
by	NULL
4	NULL
and	NULL
5	NULL
nucleotides	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
resulting	NULL
polarity	NULL
established	NULL
by	NULL
this	NULL
protein-protein	NULL
interaction	NULL
places	NULL
RXR	NULL
in	NULL
the	NULL
5'-position	NULL
or	NULL
5'-RXR-RAR-3	NULL
'	NULL
)	NULL
of	NULL
the	NULL
direct	NULL
repeats	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
either	NULL
5'-T	NULL
,	NULL
;	NULL
R-VDR-3	NULL
'	NULL
or	NULL
5-VDR-T	NULL
;	NULL
R-3	NULL
'	NULL
heterodimeric	NULL
complex	NULL
can	NULL
be	NULL
controlled	NULL
by	NULL
the	NULL
ligand	NULL
for	NULL
the	NULL
downstream	NULL
receptor	NULL
.	NULL

Thus	NULL
,	NULL
polarity	NULL
is	NULL
an	NULL
important	NULL
regulatory	NULL
property	NULL
of	NULL
heterodimeric	NULL
nuclear	NULL
TR2RE	NULL
in	NULL
the	NULL
SV40-MLP	NULL
5439	NULL
e	NULL
Syr	NULL
‘	NULL
égngfgy	NULL
CAT	NULL
pCAT-Promoter	NULL
(	NULL
a	NULL
)	NULL
``	NULL
anz	NULL
SV40	NULL
Early	NULL
--	NULL
|	NULL
TR2RE	NULL
:	NULL
P	NULL
romorer	NULL
CAT	NULL
_|_	NULL
pSV5S5wt1	NULL
(	NULL
b	NULL
)	NULL
=	NULL
--	NULL
--	NULL
--	NULL
-	NULL
T	NULL
Mutant	NULL
SV40	NULL
Early	NULL
V55mut1	NULL
(	NULL
c	NULL
|	NULL
maite	NULL
||	NULL
Pomo	NULL
J|	NULL
_CAT	NULL
_	NULL
]	NULL
PMM	NULL
CC	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

TR2RE	NULL
may	NULL
function	NULL
as	NULL
a	NULL
repressor	NULL
in	NULL
vitro	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
structure	NULL
of	NULL
the	NULL
reporter	NULL
plasmids	NULL
containing	NULL
either	NULL
the	NULL
wild-type	NULL
or	NULL
mutant	NULL
TR2RE	NULL
in	NULL
parent	NULL
pCAT-promoter	NULL
vector	NULL
.	NULL

One	NULL
copy	NULL
of	NULL
the	NULL
B	NULL
wild-type	NULL
and	NULL
mutant	NULL
TRZRE	NULL
with	NULL
the	NULL
same	NULL
direction	NULL
as	NULL
the	NULL
promoter	NULL
and	NULL
CAT	NULL
pSGS5-TR2	NULL
:	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
gene	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
pCAT-promoter	NULL
R	NULL
fer	NULL
:	NULL
a	NULL
a	NULL
b	NULL
b	NULL
¢	NULL
e	NULL
vector	NULL
(	NULL
a	NULL
)	NULL
at	NULL
the	NULL
blunted	NULL
Bg/II	NULL
site	NULL
,	NULL
epoties	NULL
:	NULL
termed	NULL
pSV55wt1	NULL
(	NULL
b	NULL
)	NULL
and	NULL
pSV55mut1	NULL
(	NULL
c	NULL
)	NULL
,	NULL
Serum	NULL
:	NULL
CTS	NULL
FBS	NULL
CTS	NULL
FBS	NULL
CTS	NULL
FBS	NULL
respectively	NULL
.	NULL

B	NULL
,	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
expression	NULL
plasmid	NULL
pSG5-TR2	NULL
and	NULL
different	NULL
.	NULL

reporter	NULL
plasmids	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
nor-	NULL
,	NULL
mal	NULL
FBS	NULL
or	NULL
CTS	NULL
.	NULL

All	NULL
CAT	NULL
assays	NULL
were	NULL
®	NULL
normalized	NULL
for	NULL
the	NULL
level	NULL
of	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Each	NULL
value	NULL
represents	NULL
the	NULL
mean	NULL
.	NULL

.	NULL

%	NULL
0	NULL
0	NULL
.	NULL

+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
relative	NULL
folds	NULL
of	NULL
CAT	NULL
conversion	NULL
from	NULL
150	NULL
the	NULL
cotransfection	NULL
with	NULL
pSGS5-TR2	NULL
and	NULL
parent	NULL
pCAT-promoter	NULL
vector	NULL
(	NULL
a	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
pSV55wt1	NULL
(	NULL
b	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
or	NULL
pSV55mut1	NULL
(	NULL
c	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
in	NULL
the	NULL
pres-	NULL
a	NULL
ence	NULL
of	NULL
FBS	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
or	NULL
CTS	NULL
Ke	NULL
]	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

8	NULL
100	NULL
S	NULL
O	NULL
yo	NULL
i	NULL
3	NULL
50	NULL
3	NULL
2	NULL
0	NULL
_I	NULL
receptor	NULL
complexes	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
TR3	NULL
orphan	NULL
receptor	NULL
,	NULL
another	NULL
orphan	NULL
receptor	NULL
identified	NULL
initially	NULL
in	NULL
our	NULL
laboratory	NULL
,	NULL
was	NULL
used	NULL
here	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
in	NULL
the	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
TR3	NULL
orphan	NULL
receptor	NULL
,	NULL
a	NULL
human	NULL
homologue	NULL
of	NULL
rat	NULL
NGFTI-B	NULL
and	NULL
mouse	NULL
nur77	NULL
,	NULL
is	NULL
also	NULL
a	NULL
member	NULL
of	NULL
the	NULL
steroid-thyroid	NULL
hormone	NULL
receptor	NULL
superfamily	NULL
(	NULL
27-29	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
rat	NULL
NGFTI-B	NULL
can	NULL
bind	NULL
to	NULL
a	NULL
response	NULL
element	NULL
(	NULL
NBRE	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
only	NULL
one	NULL
AGGTCA	NULL
half-site	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
NGFI-B	NULL
has	NULL
been	NULL
grouped	NULL
into	NULL
a	NULL
special	NULL
monomer	NULL
binding	NULL
subfamily	NULL
.	NULL

Herein	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
TR3	NULL
orphan	NULL
receptor	NULL
can	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
TRZ2RE	NULL
,	NULL
an	NULL
imperfect	NULL
direct	NULL
repeat	NULL
sequence	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
in	NULL
good	NULL
agreement	NULL
with	NULL
the	NULL
data	NULL
from	NULL
NGFI-B	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
binding	NULL
affinity	NULL
between	NULL
some	NULL
members	NULL
of	NULL
the	NULL
ERE	NULL
subfamily	NULL
and	NULL
the	NULL
TR2RE	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
prefers	NULL
TR2RE	NULL
to	NULL
other	NULL
natural	NULL
HREs	NULL
,	NULL
such	NULL
as	NULL
T	NULL
;	NULL
RE	NULL
,	NULL
RARE	NULL
,	NULL
and	NULL
NBRE	NULL
.	NULL
``	NULL

The	NULL
binding	NULL
affinity	NULL
between	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
and	NULL
the	NULL
TR2RE	NULL
is	NULL
high	NULL
and	NULL
specific	NULL
.	NULL

Interest-ingly	NULL
,	NULL
sequence	NULL
analysis	NULL
of	NULL
the	NULL
TR2RE	NULL
in	NULL
the	NULL
GenBank	NULL
data	NULL
base	NULL
indicated	NULL
that	NULL
human	NULL
hepatitis	NULL
B	NULL
virus	NULL
and	NULL
human	NULL
pap-illomavirus	NULL
type	NULL
33	NULL
may	NULL
also	NULL
contain	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

Whether	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
has	NULL
any	NULL
*	NULL
T.	NULL
Lin	NULL
and	NULL
C.	NULL
Chang	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

function	NULL
in	NULL
these	NULL
viral	NULL
gene	NULL
expressions	NULL
could	NULL
be	NULL
an	NULL
interesting	NULL
question	NULL
to	NULL
ask	NULL
.	NULL

Lydon	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
showed	NULL
that	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
is	NULL
not	NULL
constitutively	NULL
active	NULL
.	NULL

The	NULL
chimera	NULL
receptor	NULL
(	NULL
PR/PR/TR2	NULL
)	NULL
,	NULL
which	NULL
replaces	NULL
the	NULL
ligand-binding	NULL
domain	NULL
of	NULL
progesterone	NULL
receptor	NULL
with	NULL
that	NULL
of	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
,	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
dopamine	NULL
,	NULL
a	NULL
neurotransmitter	NULL
.	NULL

Our	NULL
previous	NULL
report	NULL
(	NULL
28	NULL
)	NULL
showed	NULL
that	NULL
chimeric	NULL
receptor	NULL
TR3/AR/TR3	NULL
can	NULL
be	NULL
constitutively	NULL
activated	NULL
in	NULL
both	NULL
COS1	NULL
and	NULL
prostate	NULL
PC-3	NULL
cells	NULL
but	NULL
not	NULL
TR2/AR/TR2	NULL
.	NULL

These	NULL
two	NULL
independent	NULL
data	NULL
all	NULL
suggested	NULL
that	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
may	NULL
need	NULL
its	NULL
cognate	NULL
ligand	NULL
for	NULL
the	NULL
activation	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
data	NULL
indicated	NULL
that	NULL
this	NULL
TR2RE	NULL
is	NULL
indeed	NULL
the	NULL
first	NULL
identified	NULL
natural	NULL
HRE	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

Moreover	NULL
,	NULL
our	NULL
results	NULL
showing	NULL
that	NULL
TR2RE	NULL
can	NULL
function	NULL
as	NULL
a	NULL
repressor	NULL
for	NULL
the	NULL
SV40	NULL
gene	NULL
expression	NULL
may	NULL
suggest	NULL
that	NULL
several	NULL
potential	NULL
HREs	NULL
for	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
could	NULL
exist	NULL
in	NULL
other	NULL
viruses	NULL
.	NULL

This	NULL
prediction	NULL
may	NULL
open	NULL
a	NULL
new	NULL
chapter	NULL
for	NULL
the	NULL
study	NULL
of	NULL
interaction	NULL
between	NULL
the	NULL
viral	NULL
expression	NULL
and	NULL
the	NULL
TR2	NULL
orphan	NULL
receptor	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
Janet	NULL
E.	NULL
Mertz	NULL
for	NULL
valuable	NULL
discussions	NULL
and	NULL
mutant	NULL
TRZ2RE	NULL
primers	NULL
,	NULL
Dr.	NULL
Ajit	NULL
K.	NULL
Verma	NULL
for	NULL
pRSV-8-galactosidase	NULL
plasmid	NULL
,	NULL
Dr.	NULL
Atsushi	NULL
Mizokami	NULL
for	NULL
pSVL-GR	NULL
plasmid	NULL
,	NULL
and	NULL
Yi-Fen	NULL
Lee	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
Alan	NULL
5440	NULL
Saltzman	NULL
and	NULL
Donald	NULL
Itkin	NULL
for	NULL
helpful	NULL
comments	NULL
and	NULL
editing	NULL
on	NULL
the	NULL
manuscript	NULL
,	NULL
respectively	NULL
.	NULL

~	NULL
orf	NULL
im	NULL
to	NULL
K9	NULL
i	NULL
w	NULL
Go	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

REFERENCES	NULL
.	NULL

Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
240	NULL
,	NULL
889-895	NULL
.	NULL

Beato	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
56	NULL
,	NULL
335-344	NULL
.	NULL

O'Malley	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
and	NULL
Conneely	NULL
,	NULL
O.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

6	NULL
,	NULL
1359-1361	NULL
.	NULL

Chang	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Kokontis	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

155	NULL
,	NULL
971-977	NULL
.	NULL

Chang	NULL
,	NULL
C.	NULL
,	NULL
Kokontis	NULL
,	NULL
J.	NULL
,	NULL
Acakpo-Satchivi	NULL
,	NULL
L.	NULL
,	NULL
Liao	NULL
,	NULL
S.	NULL
,	NULL
Takeda	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

165	NULL
,	NULL
735-741	NULL
.	NULL

Giguere	NULL
,	NULL
V.	NULL
,	NULL
Yang	NULL
,	NULL
N.	NULL
,	NULL
Segui	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
381	NULL
,	NULL
91-94	NULL
.	NULL

Kokontis	NULL
,	NULL
J.	NULL
,	NULL
Nakamoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
of	NULL
Prostate	NULL
Cancer	NULL
,	NULL
pp	NULL
.	NULL

220-234	NULL
,	NULL
Plenum	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Umesono	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
1139-1146	NULL
.	NULL

Martinez	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Wahli	NULL
,	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Nuclear	NULL
Hormone	NULL
Receptors	NULL
,	NULL
pp	NULL
.	NULL

125-153	NULL
,	NULL
Academic	NULL
Press	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
Wiley	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Kraus	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Zuo	NULL
,	NULL
F.	NULL
,	NULL
Murray	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
Loritz	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Mertz	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2206-2219	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Luckow	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Schutz	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
,	NULL
5490	NULL
Mowszowicz	NULL
,	NULL
L.	NULL
,	NULL
Lee	NULL
,	NULL
H.-J	NULL
.	NULL

,	NULL
Chen	NULL
,	NULL
H.-T.	NULL
,	NULL
Mestayer	NULL
,	NULL
C.	NULL
,	NULL
Portois	NULL
,	NULL
M.-C.	NULL
,	NULL
Cabrol	NULL
,	NULL
S.	NULL
,	NULL
Mauvais-Jarvis	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

7	NULL
,	NULL
861-869	NULL
Lee	NULL
,	NULL
H.-J	NULL
.	NULL

,	NULL
Kokontis	NULL
,	NULL
J.	NULL
,	NULL
Wang	NULL
,	NULL
K.-C.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

194	NULL
,	NULL
97-103	NULL
Talbot	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Altman	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Biochemistry	NULL
38	NULL
,	NULL
1999-1405	NULL
16	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

TR2RE	NULL
in	NULL
the	NULL
SV40-MLP	NULL
.	NULL

Schrader	NULL
,	NULL
M.	NULL
,	NULL
Becker-Andre	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Carlberg	NULL
,	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
6444-6449	NULL
Sagami	NULL
,	NULL
I.	NULL
,	NULL
Tsai	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Wang	NULL
,	NULL
H.	NULL
,	NULL
Tsai	NULL
,	NULL
M.-J	NULL
.	NULL

,	NULL
and	NULL
O'Malley	NULL
,	NULL
B.	NULL
W.	NULL
(	NULL
1986	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6	NULL
,	NULL
4259-4267	NULL
Chen	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Okayama	NULL
,	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
2745-2752	NULL
Tooze	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Molecular	NULL
Biology	NULL
of	NULL
Tumor	NULL
Viruses	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Cooney	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Tsai	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
O'Malley	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
and	NULL
Tsai	NULL
,	NULL
M.-J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

65	NULL
,	NULL
2853-2860	NULL
Garcia	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Ostapchuk	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Hearing	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

67	NULL
,	NULL
3940-3950	NULL
Bruggemeier	NULL
,	NULL
U.	NULL
,	NULL
Rogge	NULL
,	NULL
L.	NULL
,	NULL
Winnacker	NULL
,	NULL
E.-L.	NULL
,	NULL
and	NULL
Beato	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
2233-2239	NULL
Naar	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Boutin	NULL
,	NULL
J.-M.	NULL
,	NULL
Lipkin	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Yu	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
Holloway	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Glass	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
and	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
1267-1279	NULL
Truss	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Beato	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Endocr	NULL
.	NULL

Rev	NULL
.	NULL

14	NULL
,	NULL
459-479	NULL
Perlmann	NULL
,	NULL
T.	NULL
,	NULL
Rangarajan	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Umesono	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1411-1422	NULL
Schrader	NULL
,	NULL
M.	NULL
,	NULL
Muller	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Nayeri	NULL
,	NULL
S.	NULL
,	NULL
Kahlen	NULL
,	NULL
J.-P.	NULL
,	NULL
and	NULL
Carlberg	NULL
,	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
370	NULL
,	NULL
382-386	NULL
Chang	NULL
,	NULL
C.	NULL
,	NULL
Kokontis	NULL
,	NULL
J.	NULL
,	NULL
Liao	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

34	NULL
,	NULL
391-395	NULL
Kokontis	NULL
,	NULL
J.	NULL
,	NULL
Liao	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Receptor	NULL
1	NULL
,	NULL
261-270	NULL
Chang	NULL
,	NULL
C.	NULL
,	NULL
Saltzman	NULL
,	NULL
A.	NULL
,	NULL
Lee	NULL
,	NULL
H.-J	NULL
.	NULL

,	NULL
Uemura	NULL
,	NULL
H.	NULL
,	NULL
Su	NULL
,	NULL
C.	NULL
,	NULL
Chodak	NULL
,	NULL
G.	NULL
,	NULL
Nakamoto	NULL
,	NULL
T.	NULL
,	NULL
Le	NULL
Beau	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Espinosa	NULL
,	NULL
R.	NULL
,	NULL
Davis	NULL
,	NULL
E.	NULL
,	NULL
Lemons	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Sivak	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Shih	NULL
,	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Endocrine	NULL
J	NULL
.	NULL

1	NULL
,	NULL
541-549	NULL
Wilson	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
Fabhrner	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Johnston	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Milbrandt	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
252	NULL
,	NULL
1296-1300	NULL
Lydon	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Power	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
and	NULL
Conneely	NULL
,	NULL
O.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Gene	NULL
Expr	NULL
.	NULL

2	NULL
,	NULL
273-283	NULL

